-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MdnwGv4DJmpWpZaFNdYTBSrtJvrIOM8ntAf95yTsdRB+qh1Md72FT6KX0alsUZxb 997ibM4KNJIN2rgB0B5FUw== 0000950134-09-002590.txt : 20090212 0000950134-09-002590.hdr.sgml : 20090212 20090212150812 ACCESSION NUMBER: 0000950134-09-002590 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20090212 DATE AS OF CHANGE: 20090212 GROUP MEMBERS: ANSBERT GADICKE GROUP MEMBERS: KURT WHEELER GROUP MEMBERS: LUKE EVNIN GROUP MEMBERS: MICHAEL STEINMETZ GROUP MEMBERS: MPM ASSET MANAGEMENT II LLC GROUP MEMBERS: MPM ASSET MANAGEMENT II, L.P. GROUP MEMBERS: MPM ASSET MANAGEMENT INVESTORS 2001 LLC GROUP MEMBERS: MPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KG GROUP MEMBERS: MPM BIOVENTURES II-QP, L.P. GROUP MEMBERS: MPM BIOVENTURES III GP, L.P. GROUP MEMBERS: MPM BIOVENTURES III LLC GROUP MEMBERS: MPM BIOVENTURES STRATEGIC FUND, L.P. GROUP MEMBERS: NICHOLAS GALAKATOS SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AFFYMAX INC CENTRAL INDEX KEY: 0001158223 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82530 FILM NUMBER: 09594284 BUSINESS ADDRESS: STREET 1: 4001 MIRANDA AVE CITY: PALO ALTO STATE: CA ZIP: 94304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MPM BIOVENTURES II LP CENTRAL INDEX KEY: 0001264829 IRS NUMBER: 043523685 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: THE JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174259200 MAIL ADDRESS: STREET 1: THE JOHN HANCOCK TOWER STREET 2: 200 CLARENDON STREET, 54TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 SC 13G/A 1 f51498bsc13gza.htm AMENDMENT TO SCHEDULE 13G sc13gza
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
AFFYMAX, INC.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
00826A 10 9
(CUSIP Number)
December 31, 2008
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
  o   Rule 13d-1(b)
 
  o   Rule 13d-1(c)
 
  þ   Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
Page 1 of 23

 

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures II, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   109,213
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   109,213
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  109,213
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.7%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 2 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures II-QP, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   989,697
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   989,697
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  989,697
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  6.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 3 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Germany
       
  5   SOLE VOTING POWER
     
NUMBER OF   348,491
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   348,491
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  348,491
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  2.3%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 4 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM Asset Management Investors 2001 LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   20,548
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   20,548
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  20,548
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.1%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO

Page 5 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures Strategic Fund, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   132,520
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   0
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   132,520
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    0
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  132,520
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN

Page 6 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM Asset Management II, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,447,401*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,447,401*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,447,401*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
* The shares are held as follows: 989,697 by MPM BioVentures II-QP, L.P. (“BV II QP”); 109,213 by MPM BioVentures II, L.P. (“BV II”); and 348,491 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG (“BV KG”). The Reporting Person is the direct general partner of BV II QP, BV II and BV KG.

Page 7 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM Asset Management II LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,447,401*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,447,401*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,447,401*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  9.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO
* The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; and 348,491 by BV KG. The Reporting Person is the indirect general partner of BV II QP, BV II and BV KG.

Page 8 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures III GP, L.P.
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   132,520*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    132,520*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  132,520*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  PN
* The shares are held by MPM BioVentures Strategic Fund, L.P. (“MPM SF”). The Reporting Person is the direct general partner of MPM SF.

Page 9 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
MPM BioVentures III LLC
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  Delaware
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   132,520*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    132,520*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  132,520*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  0.9%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  OO
* The shares are held by MPM SF. The Reporting Person is the indirect general partner of MPM SF.

Page 10 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
Ansbert Gadicke
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,600,469*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,600,469*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,600,469*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by MPM Asset Management Investors 2001 LLC (“AM 2001”); 348,491 by BV KG; and 132,520 by MPM SF. MPM Asset Management II, L.P. (“AM LP”) and MPM Asset Management II LLC (“AM II LLC”) are the direct and indirect general partners of BV II QP, BV II and BV KG. MPM BioVentures III GP, L.P. (“BV III GP”) and MPM BioVentures III LLC (“BV III LLC”) are the direct and indirect general partners of MPM SF. The Reporting Person is an investment manager of AM II LLC and AM 2001 and a Series A member of BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.

Page 11 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
Luke Evnin
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,600,469*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,600,469*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,600,469*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by AM 2001; 348,491 by BV KG; and 132,520 by MPM SF. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF. The Reporting Person is an investment manager of AM II LLC and AM 2001 and a Series A member of BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.

Page 12 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
Nicholas Galakatos
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   10,000*
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,600,469**
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   10,000*
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,600,469**
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,610,469* **
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* Includes 10,000 shares issuable pursuant to options exercisable within 60 days of December 31, 2008.
** The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by AM 2001; 348,491 by BV KG; and 132,520 by MPM SF. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF. The Reporting Person is an investment manager of AM II LLC and AM 2001 and a Series A member of BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.

Page 13 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
Michael Steinmetz
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,600,469*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,600,469*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,600,469*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by AM 2001; 348,491 by BV KG; and 132,520 by MPM SF. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF. The Reporting Person is an investment manager of AM II LLC and AM 2001 and a Series A member of BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.

Page 14 of 23

 

                     
CUSIP No.
  
00826A 10 9 
  

 

           
1   NAME OF REPORTING PERSONS
Kurt Wheeler
     
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
  (a)   o
  (b)   þ
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  United States
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,600,469*
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,600,469*
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,600,469*
     
10   CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  10.5%
     
12   TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
   
  IN
* The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by AM 2001; 348,491 by BV KG; and 132,520 by MPM SF. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF. The Reporting Person is an investment manager of AM II LLC and AM 2001 and a Series A member of BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.

Page 15 of 23

 

Item 1.
  (a)   Name of Issuer

Affymax, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices

4001 Miranda Avenue
Palo Alto, CA 94304
Item 2.
  (a)   Name of Person Filing
MPM BioVentures II, LP
MPM BioVentures II-QP, L.P.
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
MPM Asset Management Investors 2001 LLC
MPM BioVentures Strategic Fund, L.P.
MPM Asset Management II, L.P.
MPM Asset Management II LLC
MPM BioVentures III GP, L.P.
MPM BioVentures III LLC
Ansbert Gadicke
Luke Evnin
Nicholas Galakatos
Michael Steinmetz
Kurt Wheeler
  (b)   Address of Principal Business Office or, if none, Residence
c/o MPM Capital L.P.
The John Hancock Tower
200 Clarendon Street, 54th Floor
Boston, MA 02116
  (c)   Citizenship
All entities were organized in Delaware except MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG, which was organized in Germany. The individuals are all United States citizens.
  (d)   Title of Class of Securities
Common Stock
  (e)   CUSIP Number
00826A 10 9
    Item 3. If this statement is filed pursuant to §§240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
               Not applicable

Page 16 of 23

 

    Item 4. Ownership
          (a) Amount Beneficially Owned:
         
MPM BioVentures II, L.P.
     109,213  
MPM BioVentures II-QP, L.P.
     989,697  
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     348,491  
MPM Asset Management Investors 2001 LLC
     20,548  
MPM BioVentures Strategic Fund, L.P.
     132,520  
MPM Asset Management II, L.P.
     1,447,401 (1)
MPM Asset Management II LLC
     1,447,401 (1)
MPM BioVentures III GP, L.P.
     132,520 (2)
MPM BioVentures III LLC
     132,520 (2)
Ansbert Gadicke
     1,600,469 (3)
Luke B. Evnin
     1,600,469 (3)
Nicholas Galakatos
     1,610,469 (3)(4)
Michael Steinmetz
     1,600,469 (3)
Kurt Wheeler
     1,600,469 (3)
 
Percent of Class:
 
MPM BioVentures II, L.P.
     0.7 %
MPM BioVentures II-QP, L.P.
     6.5 %
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     2.3 %
MPM Asset Management Investors 2001 LLC
     0.1 %
MPM BioVentures Strategic Fund, L.P.
     0.9 %
MPM Asset Management II, L.P.
     9.5 %
MPM Asset Management II LLC
     9.5 %
MPM BioVentures III GP, L.P.
     0.9 %
MPM BioVentures III LLC
     0.9 %
Ansbert Gadicke
     10.5 %
Luke B. Evnin
     10.5 %
Nicholas Galakatos
     10.5 %
Michael Steinmetz
     10.5 %
Kurt Wheeler
     10.5 %
 
(b)     Number of shares as to which the person has:
 
     (i)      Sole power to vote or to direct the vote
 
MPM BioVentures II, L.P.
     109,213  
MPM BioVentures II-QP, L.P.
     989,697  
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     348,491  
MPM Asset Management Investors 2001 LLC
     20,548  
MPM BioVentures Strategic Fund, L.P.
     132,520  
MPM Asset Management II, L.P.
     0  

Page 17 of 23

 

         
MPM Asset Management II LLC
     0  
MPM BioVentures III GP, L.P.
     0  
MPM BioVentures III LLC
     0  
Ansbert Gadicke
     0  
Luke B. Evnin
     0  
Nicholas Galakatos
     10,000 (4)
Michael Steinmetz
     0  
Kurt Wheeler
     0  
  (ii)   Shared power to vote or to direct the vote
         
MPM BioVentures II, L.P.
     0  
MPM BioVentures II-QP, L.P.
     0  
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     0  
MPM Asset Management Investors 2001 LLC
     0  
MPM BioVentures Strategic Fund L.P.
     0  
MPM Asset Management II, L.P.
     1,447,401 (1)
MPM Asset Management II LLC
     1,447,401 (1)
MPM BioVentures III GP, L.P.
     132,520 (2)
MPM BioVentures III LLC
     132,520 (2)
Ansbert Gadicke
     1,600,469 (3)
Luke B. Evnin
     1,600,469 (3)
Nicholas Galakatos
     1,600,469 (3)
Michael Steinmetz
     1,600,469 (3)
Kurt Wheeler
     1,600,469 (3)
  (iii)   Sole power to dispose or to direct the disposition of
         
MPM BioVentures II, LP
     109,213  
MPM BioVentures II-QP, L.P.
     989,697  
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     348,491  
MPM Asset Management Investors 2001 LLC
     20,548  
MPM BioVentures Strategic Fund, L.P.
     132,520  
MPM Asset Management II, L.P.
     0  
MPM Asset Management II LLC
     0  
MPM BioVentures III GP, L.P.
     0  
MPM BioVentures III LLC
     0  
Ansbert Gadicke
     0  
Luke Evnin
     0  
Nicholas Galakatos
     10,000 (4)
Michael Steinmetz
     0  
Kurt Wheeler
     0  

Page 18 of 23

 

  (iv)   Shared power to dispose or to direct the disposition of
         
MPM BioVentures II, LP
     0  
MPM BioVentures II-QP, L.P.
     0  
MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG
     0  
MPM Asset Management Investors 2001 LLC
     0  
MPM BioVentures Strategic Fund L.P.
     0  
MPM Asset Management II, L.P.
     1,447,401 (1)
MPM Asset Management II LLC
     1,447,401 (1)
MPM BioVentures III GP, L.P.
     132,520 (2)
MPM BioVentures III LLC
     132,520 (2)
Ansbert Gadicke
     1,600,469 (3)
Luke B. Evnin
     1,600,469 (3)
Nicholas Galakatos
     1,600,469 (3)
Michael Steinmetz
     1,600,469 (3)
Kurt Wheeler
     1,600,469 (3)
 
(1)   The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; and 348,491 by BV KG. AM LP and AM IILLC are the direct and indirect general partners of BV II QP, BV II and BV KG.
 
(2)   The shares are held by MPM SF. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF.
 
(3)   The shares are held as follows: 989,697 by BV II QP; 109,213 by BV II; 20,548 by AM 2001; 348,491 by BV KG; and 132,520 by MPM SF. AM LP and AM II LLC are the direct and indirect general partners of BV II QP, BV II and BV KG. BV III GP and BV III LLC are the direct and indirect general partners of MPM SF. The Reporting Person is a managing member of AM II LLC and AM 2001 and BV III LLC. The Reporting Person disclaims beneficial ownership of all such shares except to the extent of his proportionate pecuniary interests therein.
 
(4)   Includes 10,000 shares issuable upon exercise of options within 60 days of December 31, 2008.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
          Not Applicable
Item 7.   Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
          Not Applicable
Item 8. Identification and Classification of Members of the Group
          Not Applicable
Item 9. Notice of Dissolution of a Group
          Not Applicable
Item 10. Certification
          Not Applicable

Page 19 of 23

 

SIGNATURE
     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 11, 2009
                     
MPM BIOVENTURES II, L.P.       MPM BIOVENTURES II-QP, L.P.    
 
                    
By:
  MPM Asset Management II, L.P.,
its General Partner 		      By:   MPM Asset Management II, L.P.,
its General Partner		    
 
                    
By:
  MPM Asset Management II LLC,
its General Partner 		      By:   MPM Asset Management II LLC,
its General Partner		    
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Luke B. Evnin    
 
                   
 
  Name: Luke B. Evnin           Name: Luke B. Evnin    
 
  Title: Investment Manager           Title: Investment Manager    
 
                    
MPM BIOVENTURES GMBH & CO. PARALLEL-BETEILIGUNGS KG       MPM ASSET MANAGEMENT INVESTORS 2001 LLC    
 
                    
By:
  MPM Asset Management II LP, in its capacity as the       By:        /s/ Luke B. Evnin    
 
  Special Limited Partner           Name: Luke B. Evnin    
 
            Title: Investment Manager    
 
                    
By:
  MPM Asset Management II LLC, its General Partner                
 
                    
By:
       /s/ Luke B. Evnin                
 
                   
 
  Name: Luke B. Evnin                
 
  Title: Investment Manager                
 
                    
MPM ASSET MANAGEMENT II LP       MPM ASSET MANAGEMENT II LLC    
 
                    
By:
  MPM Asset Management II LLC, its General Partner                
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Luke B. Evnin    
 
                   
 
  Name: Luke B. Evnin           Name: Luke B. Evnin    
 
  Title: Investment Manager           Title: Investment Manager    
 
                    
MPM BIOVENTURES STRATEGIC FUND, L.P.       MPM BIOVENTURES III GP, L.P.    
 
                    
By:
  MPM BioVentures III GP, L.P.,       By:   MPM BioVentures III LLC,    
 
  its General Partner           its General Partner    
 
                    
By:
  MPM BioVentures III LLC,       By:        /s/ Luke B. Evnin    
 
  its General Partner           Name: Luke B. Evnin    
 
              Title: Series A Member    
 
                    
By:
       /s/ Luke B. Evnin                
 
                   
 
  Name: Luke B. Evnin                
 
  Title: Series A Member                

Page 20 of 23

 

                     
MPM BIOVENTURES III LLC                
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Ansbert Gadicke    
 
                   
 
  Name: Luke B. Evnin           Ansbert Gadicke    
 
  Title: Series A Member                
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Nicholas Galakatos    
 
                   
 
  Luke B. Evnin           Nicholas Galakatos    
 
                    
By:
       /s/ Michael Steinmetz       By:        /s/ Kurt Wheeler    
 
                   
 
  Michael Steinmetz           KurtWheeler    
EXHIBITS
A: Joint Filing Agreement

Page 21 of 23

EX-99.A 2 f51498bexv99wa.htm EX-99.A exv99wa
EXHIBIT A
JOINT FILING AGREEMENT
     In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of Affymax, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
     In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 11th day of February, 2009.
                     
MPM BIOVENTURES II, L.P.       MPM BIOVENTURES II-QP, L.P.    
 
                    
By:
  MPM Asset Management II, L.P.,
its General Partner 		      By:   MPM Asset Management II, L.P.,
its General Partner		    
 
                    
By:
  MPM Asset Management II LLC,
its General Partner 		      By:   MPM Asset Management II LLC,
its General Partner		    
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Luke B. Evnin    
 
                   
 
  Name: Luke B. Evnin           Name: Luke B. Evnin    
 
  Title: Investment Manager           Title: Investment Manager    
 
                    
MPM BIOVENTURES GMBH & CO. PARALLEL-       MPM ASSET MANAGEMENT INVESTORS 2001 LLC    
BETEILIGUNGS KG                
 
                    
By:
  MPM Asset Management II LP, in its capacity as the Special Limited Partner       By:        /s/ Luke B. Evnin    
 
                   
          Name: Luke B. Evnin    
            Title: Investment Manager    
 
                    
By:
  MPM Asset Management II LLC, its General Partner        
 
                    
By:
       /s/ Luke B. Evnin          
 
                   
 
  Name: Luke B. Evnin              
 
  Title: Investment Manager              
 
                    
MPM ASSET MANAGEMENT II LP       MPM ASSET MANAGEMENT II LLC    
 
                    
By:
  MPM Asset Management II LLC, its General Partner            
 
                    
By:
       /s/ Luke B. Evnin      
By:
       /s/ Luke B. Evnin    
 
                   
 
  Name: Luke B. Evnin           Name: Luke B. Evnin    
 
  Title: Investment Manager           Title: Investment Manager    
 
                    
MPM BIOVENTURES STRATEGIC FUND, L.P.       MPM BIOVENTURES III GP, L.P.    
 
                    
By:
  MPM BioVentures III GP, L.P., its General Partner       By:   MPM BioVentures III LLC,
its General Partner		    
 
                    
By:
  MPM BioVentures III LLC,
its General Partner 		           
 
                  
By:
       /s/ Luke B. Evnin       By:        /s/ Luke B. Evnin    
 
                   
 
  Name: Luke B. Evnin           Name: Luke B. Evnin    
 
  Title: Series A Member           Title: Investment Manager     

Page 22 of 23

 

                     
MPM BIOVENTURES III LLC                
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Ansbert Gadicke    
 
                   
 
  Name: Luke B. Evnin           Ansbert Gadicke    
 
  Title: Series A Member                
 
                    
By:
       /s/ Luke B. Evnin       By:        /s/ Nicholas Galakatos    
 
                   
 
  Luke B. Evnin           Nicholas Galakatos    
 
                    
By:
       /s/ Michael Steinmetz       By:        /s/ Kurt Wheeler    
 
                   
 
  Michael Steinmetz           Kurt Wheeler    

Page 23 of 23

-----END PRIVACY-ENHANCED MESSAGE-----